The Akt/FoxO1/p27 pathway mediates the proliferative action of liraglutide in β cells

Molecular Medicine Reports

Volumn 5, Issue 1, 2012, Pages 233-238

  Fang, Donghong ^a   Huang, Zhimin ^a   Guan, Hongyu ^a   Liu, Jianbin ^a   Yao, Bin ^a   Xiao, Haipeng ^a   Li, Yanbing ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

cell; Akt; FoxO1; Liraglutide; p27; Proliferation

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; LIRAGLUTIDE; MESSENGER RNA; PROTEIN KINASE B; PROTEIN P27; TRANSCRIPTION FACTOR FKHR;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; INSULINOMA; NONHUMAN; PANCREAS ISLET BETA CELL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE; CELL PROLIFERATION; CHROMONES; CYCLIN-DEPENDENT KINASE INHIBITOR P27; ENZYME INHIBITORS; FORKHEAD TRANSCRIPTION FACTORS; GLUCAGON-LIKE PEPTIDE 1; HUMANS; INSULIN-SECRETING CELLS; MORPHOLINES; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RNA, MESSENGER; SIGNAL TRANSDUCTION;

RATTUS;

EID: 84855238147     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2011.607     Document Type: Article

References (27)

1. Siegel EG, Gallwitz B, Scharf G, et al.: Biological activity of GLP-1-analogues with N-terminal modifications. Regul Pept 79: 93-102, 1999. (Pubitemid 29376393)
2. Sturis J, Gotfredsen CF, Romer J, et al.: GLP-1 derivative liraglutide in rats with beta-cell deficiencies: influence of metabolic state on beta-cell mass dynamics. Br J Pharmacol 140: 123-132, 2003. (Pubitemid 37175838)
3. Toso C, McCall M, Emamaullee J, et al.: Liraglutide, a long-acting human glucagon-like peptide 1 analogue, improves human islet survival in culture. Transpl Int 23: 259-265, 2010.
4. Bregenholt S, Moldrup A, Blume N, et al.: The long-acting glucagon-like peptide-1 analogue, liraglutide, inhibits beta-cell apoptosis in vitro. Biochem Biophys Res Commun 330: 577-584, 2005. (Pubitemid 40417684)
5. Liang J, Zubovitz J, Petrocelli T, et al.: PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat Med 8: 1153-1160, 2002. (Pubitemid 35175971)
6. Ciarallo S, Subramaniam V, Hung W, et al.: Altered p27(Kip1) phosphorylation, localization, and function in human epithelial cells resistant to transforming growth factor beta-mediated G(1) arrest. Mol Cell Biol 22: 2993-3002, 2002. (Pubitemid 34437458)
7. Rachdi L, Balcazar N, Elghazi L, et al.: Differential effects of p27 in regulation of beta-cell mass during development, neonatal period, and adult life. Diabetes 55: 3520-3528, 2006. (Pubitemid 44923613)
8. Glauser DA and Schlegel W: The emerging role of FOXO transcription factors in pancreatic beta cells. J Endocrinol 193: 195-207, 2007.
9. Schmidt M, Fernandez de Mattos S, van der Horst A, et al.: Cell cycle inhibition by FoxO forkhead transcription factors involves downregulation of cyclin D. Mol Cell Biol 22: 7842-7852, 2002. (Pubitemid 35217295)
10. Kitamura T and Ido Kitamura Y: Role of FoxO proteins in pancreatic beta cells. Endocr J 54: 507-515, 2007. (Pubitemid 47414596)
11. Buteau J, Spatz ML and Accili D: Transcription factor FoxO1 mediates glucagon-like peptide-1 effects on pancreatic beta-cell mass. Diabetes 55: 1190-1196, 2006. (Pubitemid 44195354)
12. Buteau J, Foisy S, Rhodes CJ, Carpenter L, Biden TJ and Prentki M: Protein kinase Czeta activation mediates glucagon-like peptide-1-induced pancreatic beta-cell proliferation. Diabetes 50: 2237-2243, 2001. (Pubitemid 33641907)
13. Rossi MC and Nicolucci A: Liraglutide in type 2 diabetes: from pharmacological development to clinical practice. Acta Biomed 80: 93-101, 2009.
14. Cheng M, Olivier P, Diehl JA, et al.: The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J 18: 1571-1583, 1999. (Pubitemid 29127070)
15. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA and Butler PC: Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52: 102-110, 2003. (Pubitemid 36042113)
16. Vilsboll T, Brock B, Perrild H, et al.: Liraglutide, a once-daily human GLP-1 analogue, improves pancreatic B-cell function and arginine-stimulated insulin secretion during hyperglycaemia in patients with Type 2 diabetes mellitus. Diabet Med 25: 152-156, 2008. (Pubitemid 351293400)
17. Shimoda M, Kanda Y, Hamamoto S, et al.: The human glucagon-like peptide-1 analogue liraglutide preserves pancreatic beta cells via regulation of cell kinetics and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes. Diabetologia 54: 1098-1108, 2011.
18. Vedtofte L, Bodvarsdottir TB, Gotfredsen CF, Karlsen AE, Knudsen LB and Heller RS: Liraglutide, but not vildagliptin, restores normoglycaemia and insulin content in the animal model of type 2 diabetes, Psammomys obesus. Regul Pept 160: 106-114, 2010.
19. Friedrichsen BN, Neubauer N, Lee YC, et al.: Stimulation of pancreatic beta-cell replication by incretins involves transcriptional induction of cyclin D1 via multiple signalling pathways. J Endocrinol 188: 481-492, 2006.
20. Gu Y, Lindner J, Kumar A, Yuan W and Magnuson MA: Rictor/mTORC2 is essential for maintaining a balance between beta-cell proliferation and cell size. Diabetes 60: 827-837, 2011.
21. Hughes E and Huang C: Participation of Akt, menin, and p21 in pregnancy-induced beta-cell proliferation. Endocrinology 152: 847-855, 2011.
22. Chen GQ, Mou CY, Yang YQ, Wang S and Zhao ZW: Exercise training has beneficial anti-atrophy effects by inhibiting oxidative stress-induced MuRF1 upregulation in rats with diabetes. Life Sci 89: 44-49, 2011.
23. Fatrai S, Elghazi L, Balcazar N, et al.: Akt induces beta-cell proliferation by regulating cyclin D1, cyclin D2, and p21 levels and cyclin-dependent kinase-4 activity. Diabetes 55: 318-325, 2006. (Pubitemid 43343259)
24. Martinez SC, Cras-Meneur C, Bernal-Mizrachi E and Permutt MA: Glucose regulates Foxo1 through insulin receptor signaling in the pancreatic islet beta-cell. Diabetes 55: 1581-1591, 2006. (Pubitemid 44324110)
25. Kitamura T, Nakae J, Kitamura Y, et al.: The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic beta cell growth. J Clin Invest 110: 1839-1847, 2002. (Pubitemid 36076491)
26. Karnik SK, Hughes CM, Gu X, et al.: Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27Kip1 and p18INK4c. Proc Natl Acad Sci USA 102: 14659-14664, 2005. (Pubitemid 41457112)
27. Uchida T, Nakamura T, Hashimoto N, et al.: Deletion of Cdkn1b ameliorates hyperglycemia by maintaining compensatory hyperinsulinemia in diabetic mice. Nat Med 11: 175-182, 2005. (Pubitemid 40321353)